So much of the work on health care utilization and spending has been done based on Medicare data and the Health Care Cost Institute, which was founded by and has data from and number of large commercial health plans, has done a very good service in rectifying that. The Institute has released its report on 2012 spending, which covers persons under 65 with employer-sponsored insurance. (HCCI Report) For 2012, overall per capita growth was 4% to $4701 annually. This was a slight decrease from 2011’s 4.1% growth, but still higher than either GDP growth or the rate of general inflation. Among major service categories, hospital inpatient had a 2.4% per capita increase, which was comprised of a 2.9% decline in admissions, but a 5.4% increase in prices paid. Outpatient facility spending rose by 7.4%, with a 1.4% growth in utilization and a 6% gain in prices. Outpatient testing grew 5.1%. Professional fees, primarily to physicians, showed only 3.1% growth, with utilization increasing 1.9% and prices only 1.1%. Prescription drug use increased 7.7% for generics but declined 20.7% for brand name drugs. Prices for generics rose 5.3% and 25.4% for brand names. The generic drug price increases are leading to higher overall spending in this category. Out-of-pocket spending grew 4.8% while the payer portion rose only 3.8%, reflecting continued growth in high-deductible and higher copay plans. Per capita spending by women grew faster than for men and spending by young adults and children was relatively slower than that for other age groups. The Northeast has both the highest per capita spending and the fastest growth while the West has the lowest spending and slowest growth. Overall the report reflects the general slowdown in spending, with prices still increasing at a rate that should be concerning. The effect of reform on spending growth in 2014 is unclear. Most people will still be in plans with higher cost-sharing, but more people supposedly will be insured, which might raise per capita utilization.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace